Session Title: FP-14 Vascular Diseases and Diabetic Retinopathy IV
Session Date/Time: Saturday 13/09/2014 | 16:30-18:00
Paper Time: 17:18
Venue: Boulevard F
First Author: : N.Saxena INDIA
Co Author(s): : V. Garg A. Supriya A. Seth M. Thakkar
To assess the efficacy and safety of low fluence IMP in the treatment of CCSC in terms of resorption of sub-retinal fluid, improvement of Visual Acuity(VA), complications and side-effects associated with the procedure.
All patients underwent complete systemic and ocular examination including Visual Acuity (snellen's chart), Slit lamp Biomicroscopy using 90D and indirect ophthalmoscopy, Optical Coherence Tomography (spectral-domain), Fundus Fluorescein Angiography and contrast sensitivity(F.A.C.T. chart).
Interventional, prospective, non-comparative case series of 15 patients with CCSC with active leakage site and neurosensory detatchment (NSD0 of more than 3 months duration. All patients were submitted to single IMP session with 2 mg/kg body weight ICG and application of not more than 5.6 w/cm2 of irradiance of light at 810 nm. Patients were followed up for 4 months and were evaluated in terms of Best Corrected Visual Acuity (BCVA), optical coherence tomography, fundus fluorescein angiography and contrast sensitivity.
The mean Visual Acuity improved from (0.25) baseline to 0.6 at 4 months. Complete resolution of NSD occured in 13 (81%) patients, while resolution of leak was observed in 88.8 % of the patients at 4 months. Retinal whitening was noted in two patients immediately following the procedure and one patient reported a decrease in vision.
Low Fluence IMP may prove to be safe and relatively safe treatment modality in Chronic Central Serous Chorioretinopathy.